What is a hysterectomy?
A hysterectomy is an operation to remove a woman’s uterus. Depending on the surgical approach and the woman’s symptoms, the ovaries, fallopian tubes and/or cervix may be removed as well. You should discuss with your physician what will be removed.
A hysterectomy is an operation to remove a woman’s uterus. Depending on the surgical approach and the woman’s symptoms, the ovaries, fallopian tubes and/or cervix may be removed as well. You should discuss with your physician what will be removed.
Complete or Total Hysterectomy -removal of the uterus and cervix.
Supracervial Hysterectomy -removal of the uterus while leaving the cervix in place.
Bilateral SalpingOophorectomy -removal of the fallopian tubes and ovaries. This procedure can also be completed with a total or supracervical hysterectomy.
Radical Hysterectomy -removal of the uterus, cervix, upper part of the vagina, and supporting tissues. This type of hysterectomy is usually done in cases of invasive gynecological cancer.
Since a hysterectomy is a major surgical and permanent procedure, it is very important to discuss the options available with your physician. Make sure you receive clear answers to your questions so you can make the best choice to fit your needs.
To read more about hysterectomy procedures and choices, go to Hysterectomy Options.
To read more about risks associated with hysterectomy go to Risks of Surgery.
References:
Sources
http://www.hystersisters.com/ http://www.womenshealth.gov/
Important Note to Reader: The information in these Web pages is for your general knowledge and background only. Note that these Web pages contain information from various sources considered to be dependable. However, we make no representations, warranties or other expressed or implied warranties or guarantees regarding the accuracy, reliability or completeness of the information. Under no circumstance shall Gyrus ACMI, Inc., Olympus America Inc. and/or its or their respective affiliates, employees, consultants, agents or representatives (collectively "Gyrus") be liable for any costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be in incurred in connection with the information provided or any use thereof.
© 2010 Gyrus ACMI, Inc. All rights reserved. | Privacy Policy | Legal Notice
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
